News

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...
FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA.